Amylin Pharmaceuticals is a biopharmaceutical company based in San Diego, CA, that was founded in 1987. The company is engaged in the discovery, development and commercialization of drug candidates for the treatment of diabetes, obesity and other diseases. Currently, Amylin produces three drugs, Symlin (pramlintide acetate) and Byetta (exenatide) and Bydureon (exenatide extended-release). Amylin also is working on producing analog of human leptin...
More
Read article at Wikipedia
Drugs manufactured:
- Symlin 600 injection ,
- Byetta 10 injection ,
- SymlinPen 1000 injection ,
- Byetta 5 injection ,
- SymlinPen 1000 injection
Date founded:
- 1987